“My goal through advocacy, education, or fundraising, is that each time a woman hears those words, she will see a five-year survival rate that is better than the last woman who received the diagnosis”
2nd Annual: Hope in Every Breath Fundraiser
August 9, 2025 6:30pm- Pittsburgh's Grand Hall at The Priory
Join us for an unforgettable evening as we traverse the landscapes of France, Finland, Israel, and Switzerland – the very places Elizabeth and Sven cherished together. Indulge in authentic cuisine and drinks from these enchanting regions, curated to tantalize your taste buds and transport you straight to Europe.
Research
Laura Stabile, PhD , Associate Professor of Pharmacology & Chemical Biology at the University of Pittsburgh and a member of the Cancer Biology Program investigates how estrogen influences the immune system and lung cancer progression. Her research indicates that estrogen fosters a protumor environment, suggesting combining anti-estrogen agents with immunotherapies could enhance treatment effectiveness. Inspired by her mother's battle with cancer, she aims to improve survival through innovative therapies and predictive biomarkers.
Our History
In 2016, Elizabeth de Jong was diagnosed with terminal lung cancer. This led to the creation of Libby's Lungs, initially a fundraising effort that evolved into creating a nonprofit supporting lung cancer research and supporting patient support services cancer. By 2024, Libby’s Lungs had raised over $375,000 for cancer initiatives.
Patient support services
Libby's Lungs is committed to funding support services for lung cancer patients and their families. We recognize that facing lung cancer can be a significant financial burden, and our organization aims to offer practical assistance, empowering individuals with the resources needed to face their journey with resilience and hope.
In Elizabeth’s words.
At the heart of our mission is Elizabeth, whose unwavering passion for lung cancer education and advocacy continues to inspire us. She dedicated her efforts to increasing research funding and breaking down the stigma associated with this challenging disease.
